Athira Pharma Inc (ATHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 29,770 | 32,927 | 24,133 | 23,569 | 23,387 |
| Operating Income | -29,770 | -32,927 | -24,133 | -23,569 | -23,387 |
| Other Income | 1,950 | 2,792 | 3,944 | -766 | 2,407 |
| Pre-tax Income | -27,820 | -30,135 | -20,189 | -24,335 | -20,980 |
| Net Income Continuous | -27,820 | -30,135 | -20,189 | -24,335 | -20,980 |
| Net Income | $-27,820 | $-30,135 | $-20,189 | $-24,335 | $-20,980 |
| EPS Basic Total Ops | -7.30 | -7.90 | -5.30 | -6.50 | -5.60 |
| EPS Basic Continuous Ops | -7.34 | -7.97 | -5.34 | -6.46 | -5.58 |
| EPS Diluted Total Ops | -7.30 | -7.90 | -5.30 | -6.50 | -5.60 |
| EPS Diluted Continuous Ops | -7.34 | -7.97 | -5.34 | -6.46 | -5.58 |
| EBITDA(a) | $-29,865 | $-33,043 | $-24,118 | $-23,339 | $-23,093 |